Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Circ J. 2013;77(6):1370-9. doi: 10.1253/circj.cj-13-0453. Epub 2013 Apr 25.
Defects in mitochondrial biogenesis are well known to contribute to cardiac dysfunction. By contrast, mechanistic details of essential homeostatic mechanisms that maintain mitochondrial health in the heart are only recently being uncovered, and the pathological potential of these processes is largely hypothetical. I will review the role of mitochondrial dynamics, focusing on cyclic organelle fission and fusion, in normal and diseased hearts. Special attention is given to recent insights into the non-canonical functioning of the mitofusin 2 (Mfn2) outer mitochondrial membrane fusion protein as a regulator of sarcoplasmic-reticular calcium crosstalk and a critical determinant of mitophagic culling of damaged mitochondria. Because mitochondrial fusion in normal adult cardiomyocytes occurs so slowly and infrequently, I postulate that the major function of Mfn2 in the heart may not be to redundantly promote mitochondrial fusion with Mfn1, but to centrally orchestrate mitochondrial quality control.
线粒体生物发生的缺陷众所周知会导致心脏功能障碍。相比之下,维持心脏中线粒体健康的基本动态平衡机制的机制细节最近才被揭示出来,这些过程的病理潜力在很大程度上仍是假设的。我将回顾线粒体动力学的作用,重点关注循环细胞器的分裂和融合,在正常和患病的心脏中。特别关注最近对线粒体融合蛋白 2(Mfn2)作为肌浆网钙串扰调节剂和受损线粒体有丝分裂清除的关键决定因素的非典型功能的深入了解。由于正常成年心肌细胞中线粒体融合发生得如此缓慢和罕见,我假设 Mfn2 在心脏中的主要功能可能不是与 Mfn1 冗余地促进线粒体融合,而是集中协调线粒体的质量控制。